Coral Laboratories Ltd.
Snapshot View

View in App

Prices View details >>

305.00 -8.60 ▼-2.7%

30 January 2023, 04:01:00 PM
Volume: 291

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.corallab.com
Market Cap 109.14 Cr.
Enterprise Value(EV) 81.85 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 25.96 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 11.77 Trailing Twelve Months Ending 2022-09
Industry PE 32.78 Trailing Twelve Months Ending 2022-09
Book Value / Share 450.39 Trailing Twelve Months Ending 2022-09
Price to Book Value 0.68 Calculated using Price: 305.50
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.36 Cr. 3,572,600 Shares
FaceValue 10
Company Profile
Coral Laboratories was founded in 1994. The company is equipped with an ultra modern manufacturing unit in the state of Gujarat, Daman & today is a force to reckon with in the pharmaceutical industry; a fact which has been endorsed by the WHO GMP certification issued by the Food & Drugs Control Administration and ISO 9001-2000 Quality certification issued by American Quality Assessors.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-2.74%
1 Week
-3.39%
1 Month
-5.37%
3 Month
+18.08%
6 Month
+14.70%
1 Year
-0.73%
2 Year
+11.21%
5 Year
-57.83%
10 Year
+344.93%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 16.72 17.46 19.18 18.17 11.04 8.88 6.22 10.74 6.18
Return on Capital Employed (%) 21.24 22.22 26.93 27.23 15.91 13.44 7.86 13.35 7.87
Return on Assets (%) 13.25 14.40 15.32 14.77 9.17 7.40 5.09 8.69 5.06

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 51 59 70 109 116 114 116 137 156 161
Non Curr. Liab. 1 1 1 3 4 4 4 3 8 11
Curr. Liab. 9 12 18 19 20 18 25 28 26 40
Minority Int.
Equity & Liab. 61 72 89 131 140 136 144 168 190 211
Non Curr. Assets 23 22 25 58 68 52 48 39 59 59
Curr. Assets 37 50 65 74 72 84 96 129 131 152
Misc. Exp. not W/O
Total Assets 61 72 89 131 140 136 144 168 190 211

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 51 59 77 95 92 91 71 97 76 75
Other Income 1 3 3 3 4 5 6 4 5 7
Total Income 52 62 80 99 97 96 76 100 80 82
Total Expenditure -41 -47 -61 -72 -77 -79 -65 -81 -67 -69
PBIDT 11 15 19 27 20 18 11 20 13 13
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation -1 -3 -2 -2 -2 -2 -2 -2 -2 -2
Taxation -2 -3 -5 -8 -6 -5 -2 -4 -3 -2
Exceptional Items 0 0 1 1
PAT 8 10 12 16 12 10 7 14 9 9
Adjusted EPS 22 27 35 46 35 29 20 38 25 26

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 1 0 5 11 13 -1 -4 1 6
Cash Fr. Inv. 0 1 0 -3 -10 -13 3 -2 0 -6
Cash Fr. Finan. 0 0 0 0 0 -3 -1 4 0 0
Net Change 1 2 0 2 1 -2 1 -2 1 0
Cash & Cash Eqvt 5 7 7 9 4 2 3 1 2 3

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 71.51 71.51 71.51 71.51 71.51 71.51 71.51 71.51 71.51
Public 28.49 28.49 28.49 28.49 28.49 28.49 28.49 28.49 28.49
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Sat, 21 Jan 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Régulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that the below mentioned certificate have been reported to be lost. The holder of these shares has requested us to issue duplicate share certificate in lieu of the original.Srno Name FolioNo. Certificate No. Distinctive No.No. of Shares1.Bhagwan Pariani 0001328 9643 952606 - 952705 1002.Bhagwan Pariani 0001328 9644 952706 - 952805 1003.Bhagwan Pariani 0001328 9645 952806 - 952905 1004.Bhagwan Pariani 0001328 9646 952906 - 953005 1005.Bhagwan Pariani 0001328 9647 953006 - 953105 1006.Bharat Pariani 0001329 9648 953106 - 953205 1007.Bharat Pariani 0001329 9649 953206 - 953305 1008.Bharat Pariani 0001329 9650 953306 - 953405 1009.Bharat Pariani 0001329 9651 953406 - 953505 10010.Bharat Pariani 0001329 9652 953506 - 953605 100
Wed, 18 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 we are enclosing herewith certificate dated January 07 2023 furnished by M/s. Link Intime India Private Limited the Registrar and Share Transfer Agent of the Company for the quarter ended December 31 2022.
Mon, 16 Jan 2023
Announcement under Regulation 30 (LODR)-Resignation of Director
With reference to our announcement dated February 24 2022 and clarification requested by Listing Compliance Monitoring Team BSE Limited vide its email dated January 16 2023 upon resignation of Mr. Sanket Mehta from the post of Independent Director of the company. please find enclosed herewith revised annexure for intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 with details related to Listed entities in which that director hold directorship.

Technical Scans View Details >>

Mon, 30 Jan 2023
Close Crossing Last Month Low Close Crossing Last Month Low
Close Below Last Month Low Close Below Last Month Low
High Decrease in 1 Month High Decrease in 1 Month
High Increase in 3 Months High Increase in 3 Months
William %R Crossed -80 From Above William %R Crossed -80 From Above

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 252,338.06 1,051.70 +0.8%
Divi's Laboratories Ltd. 89,367.34 3,366.40 -0.6%
Cipla Ltd. 83,741.18 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. 72,084.75 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. 61,094.10 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. 52,291.51 1,545.05 +0.5%
Abbott India Ltd. 44,555.01 20,967.75 -1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 61.43 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-09 29.89 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-12 31.74 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.79 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.76 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.93 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-09 50.53 20,967.75 -1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.75 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-09 7.37 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-12 3.69 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.28 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.21 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.20 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-09 16.41 20,967.75 -1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 0.00 20,967.75 -1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 29.95 20,967.75 -1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 29.95 20,967.75 -1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,967.75 -1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 798.70 20,967.75 -1.2%

FAQ's On Coral Laboratories Ltd.

What is Coral Laboratories share price?
Can I buy Coral Laboratories shares now?
What is the Market Cap of Coral Laboratories?
What are the key metrics to analyse Coral Laboratories?
What is the 52 Week High and Low of Coral Laboratories?
What is the trend of Coral Laboratories share price?